JITC

ALKS 4230: a novel engineered IL-2 fusion protein with an improved cellular selectivity profile for cancer immunotherapy
Jared E Lopes, Jan L Fisher, Heather L Flick, Chunhua Wang, Lei Sun, Marc S Ernstoff, Juan C Alvarez, Heather C Losey

Journal for ImmunoTherapy of Cancer Apr 2020, 8 (1) e000673; DOI: 10.1136/jitc-2020-000673
On the mechanism of anti-CD39 immune checkpoint therapy
David Allard, Bertrand Allard, John Stagg

Journal for ImmunoTherapy of Cancer Feb 2020, 8 (1) e000186; DOI: 10.1136/jitc-2019-000186
The Society for Immunotherapy of Cancer perspective on regulation of interleukin-6 signaling in COVID-19-related systemic inflammatory response
Fernanda I Arnaldez, Steven J O'Day, Charles G Drake, Bernard A Fox, Bingqing Fu, Walter J Urba, Vincenzo Montesarchio, Jeffrey S Weber, Haiming Wei, Jon M Wigginton, Paolo Antonio Ascierto

Journal for ImmunoTherapy of Cancer May 2020, 8 (1) e000930; DOI: 10.1136/jitc-2020-000930
SOD3 induces a HIF-2α-dependent program in endothelial cells that provides a selective signal for tumor infiltration by T cells
Lorena Carmona-Rodríguez, Diego Martínez-Rey, Maria Jesús Fernández-Aceñero, Alicia González-Martín, Mateo Paz-Cabezas, Noe Rodríguez-Rodríguez, Beatriz Pérez-Villamil, Maria Eugenia Sáez, Eduardo Díaz-Rubio, Emilia Mira, Santos Mañes

Journal for ImmunoTherapy of Cancer Jun 2020, 8 (1) e000432; DOI: 10.1136/jitc-2019-000432
Immunomodulatory effects of renin–angiotensin system inhibitors on T lymphocytes in mice with colorectal liver metastases
Dora Lucia Vallejo Ardila, Katrina A Walsh, Theodora Fifis, Rita Paolini, Georgios Kastrappis, Christopher Christophi, Marcos Vinicius Perini

Journal for ImmunoTherapy of Cancer May 2020, 8 (1) e000487; DOI: 10.1136/jitc-2019-000487
Lactoferrin-containing immunocomplex mediates antitumor effects by resetting tumor-associated macrophages to M1 phenotype
Hongliang Dong, Yueyao Yang, Chenhui Gao, Hehe Sun, Hongmin Wang, Chao Hong, Jun Wang, Fangyuan Gong, Xiaoming Gao

Journal for ImmunoTherapy of Cancer Mar 2020, 8 (1) e000339; DOI: 10.1136/jitc-2019-000339
Interplay between glucocorticoids and tumor-infiltrating lymphocytes on the prognosis of adrenocortical carcinoma
Laura-Sophie Landwehr, Barbara Altieri, Jochen Schreiner, Iuliu Sbiera, Isabel Weigand, Matthias Kroiss, Martin Fassnacht, Silviu Sbiera

Journal for ImmunoTherapy of Cancer May 2020, 8 (1) e000469; DOI: 10.1136/jitc-2019-000469
EpCAM-high liver cancer stem cells resist natural killer cell–mediated cytotoxicity by upregulating CEACAM1
Dong Jun Park, Pil Soo Sung, Jung-Hee Kim, Gil Won Lee, Jeong Won Jang, Eun Sun Jung, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon

Journal for ImmunoTherapy of Cancer Mar 2020, 8 (1) e000301; DOI: 10.1136/jitc-2019-000301
Identification of PD1-mediated regulation of antitumor antigen response in patients with NSCLC using the trans vivo DTH assay
Diego A Lema, Ewa Jankowska-Gan, Nan Sethakorn, William Burlingham, Ticiana Leal

Journal for ImmunoTherapy of Cancer Jun 2020, 8 (1) e000152; DOI: 10.1136/jitc-2019-000152
Vaccine efficacy against primary and metastatic cancer with in vitro-generated CD103⁺ conventional dendritic cells
Yifan Zhou, Natalie Slone, Taylor T Chrisikos, Oleksandr Kyrysyuk, Rachel L Babcock, Yusra B Medik, Haiyan S Li, Eugenie S Kleinerman, Stephanie S Watowich

Journal for ImmunoTherapy of Cancer Apr 2020, 8 (1) e000474; DOI: 10.1136/jitc-2019-000474

Main menu

JITC

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

JITC

Pages